Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Helius Medical Technologies stock | $15.49

Own Helius Medical Technologies stock in just a few minutes.

Fact checked

Helius Medical Technologies, Inc is a medical devices business based in the US. Helius Medical Technologies shares (HSDT) are listed on the NASDAQ and all prices are listed in US Dollars. Helius Medical Technologies employs 19 staff and has a trailing 12-month revenue of around USD$622,000.

How to buy shares in Helius Medical Technologies

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Helius Medical Technologies. Find the stock by name or ticker symbol: HSDT. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Helius Medical Technologies reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$15.49, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Helius Medical Technologies, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Helius Medical Technologies. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Helius Medical Technologies share price

Use our graph to track the performance of HSDT stocks over time.

Helius Medical Technologies shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$15.49
52-week rangeUSD$0.249 - USD$1.47
50-day moving average USD$0.4019
200-day moving average USD$0.4455
Wall St. target priceUSD$2.12
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.341

Buy Helius Medical Technologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Helius Medical Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Helius Medical Technologies price performance over time

Historical closes compared with the close of $15.49 from 2021-01-11

1 week (2021-01-07) -4.97%
1 month (2020-12-15) 3,713.39%
3 months (2020-10-15) 3,502.33%
6 months (2020-07-15) 2,897.29%
1 year (2020-01-15) 1,389.42%
2 years (2019-01-15) 85.51%
3 years (2018-01-13) N/A
5 years (2016-01-15) 1,843.54%

Helius Medical Technologies financials

Revenue TTM USD$622,000
Gross profit TTM USD$650,000
Return on assets TTM -110.59%
Return on equity TTM -281.65%
Profit margin 0%
Book value $0.07
Market capitalisation USD$21 million

TTM: trailing 12 months

Shorting Helius Medical Technologies shares

There are currently 889,285 Helius Medical Technologies shares held short by investors – that's known as Helius Medical Technologies's "short interest". This figure is 0% up from 888,932 last month.

There are a few different ways that this level of interest in shorting Helius Medical Technologies shares can be evaluated.

Helius Medical Technologies's "short interest ratio" (SIR)

Helius Medical Technologies's "short interest ratio" (SIR) is the quantity of Helius Medical Technologies shares currently shorted divided by the average quantity of Helius Medical Technologies shares traded daily (recently around 166845.21575985). Helius Medical Technologies's SIR currently stands at 5.33. In other words for every 100,000 Helius Medical Technologies shares traded daily on the market, roughly 5330 shares are currently held short.

However Helius Medical Technologies's short interest can also be evaluated against the total number of Helius Medical Technologies shares, or, against the total number of tradable Helius Medical Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Helius Medical Technologies's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Helius Medical Technologies shares in existence, roughly 20 shares are currently held short) or 0.019% of the tradable shares (for every 100,000 tradable Helius Medical Technologies shares, roughly 19 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Helius Medical Technologies.

Find out more about how you can short Helius Medical Technologies stock.

Helius Medical Technologies share dividends

We're not expecting Helius Medical Technologies to pay a dividend over the next 12 months.

Have Helius Medical Technologies's shares ever split?

Helius Medical Technologies's shares were split on a 1:5 basis on 23 January 2018. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Helius Medical Technologies shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Helius Medical Technologies shares which in turn could have impacted Helius Medical Technologies's share price.

Helius Medical Technologies share price volatility

Over the last 12 months, Helius Medical Technologies's shares have ranged in value from as little as $0.249 up to $1.47. A popular way to gauge a stock's volatility is its "beta".

HSDT.US volatility(beta: 0.77)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Helius Medical Technologies's is 0.7706. This would suggest that Helius Medical Technologies's shares are less volatile than average (for this exchange).

Helius Medical Technologies overview

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site